Dr. Kizzmekia Corbett, a senior research fellow who’s spent the past 6 years working with VRC strategists in NIAID’s Viral Pathogenesis Laboratory and who’s become a central figure in covid vaccine science, recently discussed “SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.”
Doctors might one day use copper’s antimicrobial properties to treat bacterial diseases, said Dr. Michael D. L. Johnson at a recent NIGMS Director’s Early-Career Investigator Lecture. His lab is studying how Streptococcus pneumoniae bacteria, or pneumococcus, responds to copper. They are trying to answer the question: “If you punch bacteria with copper, how does it punch back?”
Four NIH women scientists recently discussed how they’re juggling their professional and personal responsibilities amid the altered schedules and uncertainty of the covid pandemic. The virtual lecture was part of EDI's Whole Woman seminar series.